@article{5a7ea69dac3e4dcf85c5e7b979a20971,
title = "Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer-Not All That Glitters Is Gold-Reply",
author = "Tran, {Phuoc T.} and Deek, {Matthew P.} and Phillips, {Ryan M.}",
note = "Funding Information: Conflict of Interest Disclosures: Dr Vaidya reported receiving grants, honoraria, and travel fees from Carl Zeiss. Drs Vaidya and Bulsara reported receiving grant funding from the Health Technology Assessment Programme of the National Institute for Health Research, UK, for TARGIT trials. Dr Baum was on the scientific advisory board of Carl Zeiss and was paid monthly consultancy fees briefly before 2010. Carl Zeiss sponsors some travel and accommodation for meetings related to TARGIT trials for all authors.",
year = "2020",
month = oct,
doi = "10.1001/jamaoncol.2020.2842",
language = "English (US)",
volume = "6",
pages = "1638--1639",
journal = "JAMA Oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "10",
}